// App-Quantinova.ai

e18018 : Utility of comprehensive genomic profiling (CGP) at an NCI-designated cancer center for identifying clinically relevant genomic alterations (CRGA) and implementing genomically directed therapy (GDT).

Researchers

Presenter

  • Talal Hilal

Principal Investigators

  • Jacob Hodskins

  • Susanne M. Arnold

  • Philip A. DeSimone

  • Lars M. Wagner

  • Lowell Brian Anthony

  • Mara D. Chambers

  • John L. Villano

  • Aju Mathew

  • Sherry L. Bayliff

  • Gaurav Goel

  • Edward H. Romond

  • Ravneet Thind

  • Peng Wang

  • Tom C. Badgett

  • John A. D'Orazio

  • Fredrick R. Ueland

  • John Van Nagell

  • Peter Joel Hosein

Medical Centers

  • Markey Cancer Center, University of Kentucky, Lexington, KY

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved